HTTP/2 301
date: Mon, 29 Dec 2025 12:58:19 GMT
content-type: text/plain; charset=utf-8
content-length: 70
location: https://biomarker.substack.com/about
server: cloudflare
cf-ray: 9b5977e0be7d741b-BLR
cf-cache-status: MISS
cache-control: no-cache
set-cookie: ab_experiment_sampled=%22false%22; Max-Age=31536000; Domain=substack.com; Path=/; Expires=Tue, 29 Dec 2026 12:58:19 GMT; HttpOnly; Secure; SameSite=Lax
set-cookie: ab_testing_id=%2289b4ab6c-47e8-4c70-acce-33f05a2fd306%22; Max-Age=31536000; Domain=substack.com; Path=/; Expires=Tue, 29 Dec 2026 12:58:19 GMT; HttpOnly; Secure; SameSite=Lax
set-cookie: __cf_bm=KMIV1kPYi9RD55f9kh..yjVQ5sWDZF5D.LVUXX_E2L4-1767013099-1.0.1.1-BFaLC9JmmgSXRmDv19Hj99yY6UScfeKW9_6yJiPETK6ePfuCYxC4nD78WSKcANmHU07sZ0eYqCNunhNB7ARSjHJsPMvcf.VRNEb1RQqkL8Y; path=/; expires=Mon, 29-Dec-25 13:28:19 GMT; domain=.substack.com; HttpOnly; Secure; SameSite=None
strict-transport-security: max-age=31536000
vary: Accept, Accept-Encoding
x-cluster: substack
x-deploy: 66ab330854
x-powered-by: Express
x-served-by: Substack
x-service: web
alt-svc: h3=":443"; ma=86400
HTTP/2 200
date: Mon, 29 Dec 2025 12:58:20 GMT
content-type: text/html; charset=utf-8
content-encoding: gzip
cf-ray: 9b5977e2dc4da9b7-BLR
cf-cache-status: MISS
cache-control: no-cache
strict-transport-security: max-age=31536000
vary: Accept-Encoding
content-security-policy: frame-ancestors 'self' https://*.substack.com https://substack.com
x-cluster: substack
x-deploy: 66ab330854
x-powered-by: Express
x-served-by: Substack
x-service: web
x-sub: biomarker
server: cloudflare
alt-svc: h3=":443"; ma=86400
About - Biomarker
How does a scientific breakthrough get from bench to bedside?
Biomarker is a free newsletter exploring how science, medicine and biotech align to deliver next generation therapeutics and tech. Through a series of interviews with experts we ask: what do storied scientists consider to be their most impactful discoveries? Which research questions keep them motivated to come into lab, and who are the most promising young investigators in their fields?
We are in the midst of an explosion in scientific discovery. Biomarker is a snapshot of the most exciting areas in translational science and medicine, and how scientists, clinicians and entrepreneurs view this work.
Interviews with scientists and industry experts.
Short interviews with founders and biotech operators.
Interviews with established investors and company creators.
Reviews of emerging areas of science and medicine
Biomarker was created by Dylan Neel, MD PhD, a neurology resident at Mass General Brigham
Share Biomarker
Subscribe to Biomarker Interviews with scientists, physicians, industry experts and investors.
This site requires JavaScript to run correctly. Please
turn on JavaScript or unblock scripts
